🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,557 results for “placebo” Clear

  1. Phytosterols & placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-alcoholic Fatty Liver Disease

    other completed

    1 trial

  2. Pitavastatin and placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dyslipidemia

    small molecule active

    1 trial

  3. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    2 trials

  4. Placebo

    KYOWA KIRIN AUSTRALIA PTY LTD

    Healthy

    other active

    1 trial

  5. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorder

    small molecule completed

    1 trial

  6. Placebo

    United Therapeutics Europe Ltd

    Healthy

    small molecule completed

    1 trial

  7. Placebo

    Hospital Authority, Hong Kong

    Chronic Kidney Disease

    other completed

    1 trial

  8. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Magnetic Resonance Imaging

    small molecule completed

    1 trial

  9. Placebo

    Regeneron Ireland Designated Activity Company (DAC)

    Knee Osteoarthritis

    small molecule active

    1 trial

  10. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    small molecule completed

    1 trial

  11. Placebo

    Hospital Authority, Hong Kong

    Hypertension in Pregnancy

    other completed

    1 trial

  12. Placebo

    United Therapeutics Europe Ltd

    Chronic Kidney Failure

    other active

    1 trial

  13. Placebo (for Motilitone)

    Samsung Bioepis NL B.V.

    Dyspepsia

    small molecule completed

    1 trial

  14. Placebo 1 to Probiotic A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastrointestinal Dysfunction

    other active

    1 trial

  15. Placebo and Escitalopram

    Takeda

    Panic Disorder

    small molecule terminated

    1 trial

  16. Placebo plus high-intensity statin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Coronary Syndrome

    small molecule active

    1 trial

  17. Sertraline plus placebo of JWXYJN

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depressive Disorder

    small molecule active

    1 trial

  18. amorphous calcium carbonate/ Placebo

    Universal Integrated

    Calcium

    other completed

    1 trial

  19. placebo

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    PCOS- Polycystic Ovary Syndrome

    other active

    1 trial

  20. placebo

    CUMBERLAND PHARMACEUTICALS INC

    Autism

    small molecule completed

    1 trial

  21. placebo (compared to vasoconstrictor)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Male

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources